New Delhi, July 31 (IANS) Kindlins, adapter proteins found in vertebrate cells could change the face of cancer treatments, research from S. N. Bose National Centre for Basic Sciences has found.
The research team, led by Debojyoti Chowdhury, analyzed data from 10,000 patients across 33 cancer types from The Cancer Genome Atlas to investigate Kindlins’ role in cancer progression, published in the journal Communications Biology, the study underscores Kindlins’ potential as targets for innovative cancer therapies.
Kindlins are proteins attached to the cell membranes in almost all vertebrate cells, crucial for converting extracellular mechanical cues into biochemical signals.
These proteins interact with structural proteins, receptors, and transcription factors, triggering a cascade of intracellular signals essential for maintaining the body’s homeostasis. Disruptions in the Kindlin structure can lead to diseases like cancer.
The study highlighted that Kindlin 1 regulates the immune microenvironment in breast cancer, while Kindlin 2 is involved in cancer-specific metabolic processes like the TCA cycle and glycolysis.
Additionally, Kindlin 2 influences HIPPO signalling, a pathway that promotes cancer cell migration and invasion.
“Kindlin 2 can also regulate HIPPO signalling, Hippo signalling is a kind of signal in cancer cells that tells the cell to migrate and invade other tissues. Kindlin 2 can also regulate HIPPO signalling,” said Debojyoti Chowdhury in a statement.
The study suggests a potential link between Kindlin dysfunction and adverse survival outcomes, providing evidence for their importance in various cancer stages and subtypes.
“By studying all Kindlin family members collectively, we can gain a comprehensive understanding of their potential complementary and synergistic roles in cancer biology,” Chowdhury added.
It offers new avenues for cancer treatment strategies, particularly in overcoming chemoresistance and tumour relapse, pivotal challenges in oncology. This research may pave the way for novel interventions in the ongoing battle against cancer.
–IANS
ts/dan
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
